294 related articles for article (PubMed ID: 9797690)
1. A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer.
Kobayashi K; Takeda F; Teramukai S; Gotoh I; Sakai H; Yoneda S; Noguchi Y; Ogasawara H; Yoshida K
Eur J Cancer; 1998 May; 34(6):810-5. PubMed ID: 9797690
[TBL] [Abstract][Full Text] [Related]
2. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
[TBL] [Abstract][Full Text] [Related]
3. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
[TBL] [Abstract][Full Text] [Related]
4. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
5. The Azeri Version of European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30): Translation and Validation.
Davudov MM; Harirchi I; Amiraliyev N; Mehtiyeva E; Mirzajani Z; Amiraliyev K; Rustamli N; Zebardast J; Montazeri A
Asian Pac J Cancer Prev; 2020 Jan; 21(1):267-271. PubMed ID: 31983195
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Korean version of the EORTC QLQ-C30.
Yun YH; Park YS; Lee ES; Bang SM; Heo DS; Park SY; You CH; West K
Qual Life Res; 2004 May; 13(4):863-8. PubMed ID: 15129896
[TBL] [Abstract][Full Text] [Related]
7. Psychometric properties of the EORTC QLQ-C30 in Uganda.
Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
[TBL] [Abstract][Full Text] [Related]
8. Psychometric Validation of the Malaysian Chinese Version of the EORTC QLQ-C30 in Colorectal Cancer Patients.
Magaji BA; Moy FM; Roslani AC; Law CW; Sagap I
Asian Pac J Cancer Prev; 2015; 16(18):8107-12. PubMed ID: 26745046
[TBL] [Abstract][Full Text] [Related]
9. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
Kontodimopoulos N; Ntinoulis K; Niakas D
Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
[TBL] [Abstract][Full Text] [Related]
10. The validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China.
Cheng JX; Liu BL; Zhang X; Zhang YQ; Lin W; Wang R; Zhang YQ; Zhang HY; Xie L; Huo JL
BMC Med Res Methodol; 2011 Apr; 11():56. PubMed ID: 21513533
[TBL] [Abstract][Full Text] [Related]
11. Assessing the acceptability, reliability, and validity of the EORTC Quality of Life Questionnaire (QLQ-C30) in Kenyan cancer patients: a cross-sectional study.
Davda J; Kibet H; Achieng E; Atundo L; Komen T
J Patient Rep Outcomes; 2021 Jan; 5(1):4. PubMed ID: 33415528
[TBL] [Abstract][Full Text] [Related]
12. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): validation study of the Thai version.
Silpakit C; Sirilerttrakul S; Jirajarus M; Sirisinha T; Sirachainan E; Ratanatharathorn V
Qual Life Res; 2006 Feb; 15(1):167-72. PubMed ID: 16411041
[TBL] [Abstract][Full Text] [Related]
13. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
[TBL] [Abstract][Full Text] [Related]
14. Testing psychometric properties of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30).
Zhao H; Kanda K
J Epidemiol; 2004 Nov; 14(6):193-203. PubMed ID: 15617393
[TBL] [Abstract][Full Text] [Related]
15. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-c30): validation of English version in Singapore.
Luo N; Fones CS; Lim SE; Xie F; Thumboo J; Li SC
Qual Life Res; 2005 May; 14(4):1181-6. PubMed ID: 16041912
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24.
Park J; Shin DW; Kim TH; Jung SI; Nam JK; Park SC; Hong S; Jung JH; Kim H; Kim WT
Cancer Res Treat; 2018 Jan; 50(1):40-49. PubMed ID: 28279061
[TBL] [Abstract][Full Text] [Related]
17. Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer.
Ihn MH; Lee SM; Son IT; Park JT; Oh HK; Kim DW; Kang SB
Support Care Cancer; 2015 Dec; 23(12):3493-501. PubMed ID: 25824366
[TBL] [Abstract][Full Text] [Related]
18. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
Aaronson NK; Ahmedzai S; Bergman B; Bullinger M; Cull A; Duez NJ; Filiberti A; Flechtner H; Fleishman SB; de Haes JC
J Natl Cancer Inst; 1993 Mar; 85(5):365-76. PubMed ID: 8433390
[TBL] [Abstract][Full Text] [Related]
19. Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13.
Chie WC; Yang CH; Hsu C; Yang PC
Qual Life Res; 2004 Feb; 13(1):257-62. PubMed ID: 15058806
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18).
Mikoshiba N; Tateishi R; Tanaka M; Sakai T; Blazeby JM; Kokudo N; Koike K; Kazuma K
Health Qual Life Outcomes; 2012 May; 10():58. PubMed ID: 22651810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
